| Standard Report | Premium Report | |
|---|---|---|
| Current State of the Industry |  |
|
| Market Size (industry trends) | |
|
| Market Forecast (5-year projection) | |
|
| Products/Services Breakdown | |
|
| Revenue per State | |
|
| Financial Metrics | |
|
| Salary & Compensation Statistics | |
|
| Public Company Information | |
|
| Key Private Companies | |
|
| Government Vendors | |
|
| Instant Download - Available immediately upon purchase | |
|
Download both PDF and Excel
|
|
|
| Download now: |
2024 U.S. Industry Statistics & Market Forecast - Research and Development in Nanotechnology
Market Size & Industry Statistics
The total U.S. industry market size for Research and Development in Nanotechnology:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
| Statistics | 2019 2020 2021 2022 2023 | |
|---|---|---|
| Market Size (Total Sales/Revenue) |
Order at top of page | |
| Total Firms | ||
| Total Employees | ||
| Average Revenue Per Firm | ||
| Average Employees Per Firm | ||
| Average Revenue Per Employee | ||
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
| Forecast / Industry Outlook | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|
| Market Forecast ($ millions) | ||||||
| Projected Industry Growth Rate (%) | ||||||
Industry Insights
The biotechnology industry has been experiencing significant changes due to emerging technologies and shifting regulatory policies. The following are some of the key trends that are affecting the Research & Development in the biotechnology industry:1. Artificial intelligence and machine learning are transforming drug discovery and research processes by accelerating the drug discovery process, enabling early identification of targets, and facilitating the development of personalized medicine.
2. The use of CRISPR-Cas9 gene editing is transforming the R&D processes by enabling scientists to modify genetic material quickly, accurately, and cost-effectively.
3. Biotech companies are focusing on developing cell and gene therapies that have the potential to cure diseases. One of the biggest drivers of this trend is the growing demand for personalized medicine.
4. Increasingly stringent regulatory policies are requiring biotech companies to streamline their R&D processes and ensure strict adherence to safety and quality standards.
5. The trend towards collaborative partnerships between biotech companies and other stakeholders such as government agencies, academic institutions, and clinical research organizations is expected to continue to grow, leading to more efficient R&D processes.
6. The biotech industry is also experiencing significant growth due to increased investment in emerging markets such as Asia, which is rapidly becoming a major hub for biotech research and development.
7. The use of Big Data analytics is transforming the R&D process by enabling researchers to better understand the molecular structures of diseases and develop more effective treatments.
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.| Industry Average | Percent of Sales (Industry Benchmark) | |
|---|---|---|
| Total Revenue | Order at top of page |
|
| Operating Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | ||
Operating Expenses | ||
| Pension, profit sharing plans, stock, annuity | ||
| Repairs | ||
| Rent paid on business property | ||
| Charitable Contributions | ||
| Depletion | ||
| Domestic production activities deduction | ||
| Advertising | ||
| Compensation of officers | ||
| Salaries and wages | ||
| Employee benefit programs | ||
| Taxes and Licenses | ||
| Bad Debts | ||
| Depreciation | ||
| Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| EBIT (Earnings Before Interest and Taxes) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Research and Development in Nanotechnology company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.| Profitability & Valuation Ratios | Industry Average |
|---|---|
| Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Research and Development in Nanotechnology industry is performing. | |
| Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
| Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
| Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Research and Development in Nanotechnology measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
|
| Liquidity Ratios | Industry Average |
|---|---|
| Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
| Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
| Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
|
| Efficiency Ratios - Key Performance Indicators | Industry Average |
|---|---|
| Measure how quickly products and services sell, and effectively collections policies are implemented. | |
| Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
| Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
| Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
| Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
|
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 19% | Order at top of page |
||
| Chief Executives | 1% | |||
| General and Operations Managers | 4% | |||
| Operations Specialties Managers | 5% | |||
| Other Management Occupations | 8% | |||
| Business and Financial Operations Occupations | 11% | |||
| Business Operations Specialists | 9% | |||
| Computer and Mathematical Occupations | 15% | |||
| Computer Occupations | 12% | |||
| Software and Web Developers, Programmers, and Testers | 7% | |||
| Software Developers | 5% | |||
| Architecture and Engineering Occupations | 15% | |||
| Engineers | 12% | |||
| Life, Physical, and Social Science Occupations | 22% | |||
| Life Scientists | 11% | |||
| Biological Scientists | 5% | |||
| Medical Scientists | 5% | |||
| Medical Scientists, Except Epidemiologists | 5% | |||
| Life, Physical, and Social Science Technicians | 6% | |||
| Office and Administrative Support Occupations | 6% | |||
Research and Development in Nanotechnology Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Research and Development in Nanotechnology industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Research and Development in Nanotechnology industry and adjacent sectors:| Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
| Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Research and Development in Nanotechnology industry. |
Source:
Innovation News
- Mar 07, 2024: Third Pole patents Systems And Methods For Nitric Oxide Generation With Humidity Control
- Mar 07, 2024: Third Pole patents Systems And Methods For Nitric Oxide Generation With Humidity Control
- Mar 07, 2024: Third Pole patents Nitric Oxide Generation
- Jan 19, 2024: Freshair Sensor trademarks "BREATHE EASY" - Electronic monitoring of active smoking of tobacco and/or marijuana or active vaping using computers and sensors
- Jan 19, 2024: Freshair Sensor trademarks "FRESHAIR CERTIFIED" - Electronic monitoring and reporting of active smoking of tobacco and/or marijuana or active vaping using computers or sensors
- Jan 19, 2024: Freshair Sensor trademarks "REST ASSURED" - Electronic monitoring of active smoking of tobacco and/or marijuana or active vaping using computers and sensors
- Apr 17, 2023: Volexion raises $2 million in funding.
- Apr 08, 2021: Volexion raises $1 million in funding.
- Aug 24, 2020: Guide Therapeutics raises $6 million in funding.
Recent Federal Contracts for Research and Development in Nanotechnology- Mar 29, 2024: NANOCOMP TECHNOLOGIES, INC. (Merrimack, NH) awarded $9,498,932
- Mar 28, 2024: NORTHROP GRUMMAN SYSTEMS CORPORATION (Linthicum Heights, MD) awarded $4,851,327
- Mar 21, 2024: HEALTH RESEARCH, INC. (Menands, NY) awarded $10,284,341
- Mar 14, 2024: TRUSTEES OF INDIANA UNIVERSITY (Indianapolis, IN) awarded $651,981
- Mar 08, 2024: LOCKHEED MARTIN CORP (Orlando, FL) awarded $4,039,236
- Mar 06, 2024: REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, MI) awarded $3,486,575
- Mar 29, 2024: NANOCOMP TECHNOLOGIES, INC. (Merrimack, NH) awarded $9,498,932
- Mar 28, 2024: NORTHROP GRUMMAN SYSTEMS CORPORATION (Linthicum Heights, MD) awarded $4,851,327
- Mar 21, 2024: HEALTH RESEARCH, INC. (Menands, NY) awarded $10,284,341
- Mar 14, 2024: TRUSTEES OF INDIANA UNIVERSITY (Indianapolis, IN) awarded $651,981
- Mar 08, 2024: LOCKHEED MARTIN CORP (Orlando, FL) awarded $4,039,236
- Mar 06, 2024: REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, MI) awarded $3,486,575
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.